89 FR 249 pgs. 106579-106580 - Bulk Manufacturer of Controlled Substances Application: Irvine Labs Inc.
Type: NOTICEVolume: 89Number: 249Pages: 106579 - 106580
Pages: 106579, 106580Docket number: [Docket No. DEA-1461]
FR document: [FR Doc. 2024-31293 Filed 12-27-24; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1461]
Bulk Manufacturer of Controlled Substances Application: Irvine Labs Inc.
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Irvine Labs Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before February 28, 2025. Such persons may also file a written request for a hearing on the application on or before February 28, 2025.
ADDRESSES:
[top] The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov . If you have received a Comment Tracking
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on August 26, 2024, Irvine Labs Inc., 7305 Murdy Circle, Huntington Beach, California 92647-3533, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):
Controlled substance | Drug code | Schedule |
---|---|---|
Lysergic acid diethylamide | 7315 | I |
Mescaline | 7381 | I |
Peyote | 7415 | I |
Diethyltryptamine | 7434 | I |
Dimethyltryptamine | 7435 | I |
Psilocybin | 7437 | I |
Psilocyn | 7438 | I |
The company plans to bulk manufacture the above listed controlled substances for research and development purposes internally and for distribution to its research customers. No other activities for these drug codes are authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2024-31293 Filed 12-27-24; 8:45 am]
BILLING CODE 4410-09-P